Evidence map›Paper›PMID 25425574›Full record

ArticleThe EMBO journal2015

Suppression of the HSF1-mediated proteotoxic stress response by the metabolic stress sensor AMPK.

Siyuan Dai, Zijian Tang, Junyue Cao, Wei Zhou, Huawen Li, Stephen Sampson, Chengkai Dai

Abstract read
In one paragraph

Article in The EMBO journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Adaptation to heat stress by diversification of the vertebrate heat shock transcription factor family.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer.Journal of experimental & clinical cancer research : CR · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. HSF1 and Its Role in Huntington's Disease Pathology.Advances in experimental medicine and biology · 2023
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Siyuan DaiThe Jackson Laboratory, Bar Harbor, ME, USA.
Zijian TangThe Jackson Laboratory, Bar Harbor, ME, USA Graduate Programs, Department of Molecular & Biomedical Sciences, The University of Maine, Orono, ME, USA.
Junyue CaoThe Jackson Laboratory, Bar Harbor, ME, USA.
Wei ZhouThe Jackson Laboratory, Bar Harbor, ME, USA.
Huawen LiThe Jackson Laboratory, Bar Harbor, ME, USA.
Stephen SampsonThe Jackson Laboratory, Bar Harbor, ME, USA.
Chengkai DaiThe Jackson Laboratory, Bar Harbor, ME, USA Chengkai.Dai@jax.org.
Jackson Laboratory · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI OLGA ANCZUKOW-CAMARDA · 1985 to 2026
$61.9M
Role of a Novel Stress Response Mechanism-Genetic Buffering-in Tumor EvolutionDP2OD007070 · OD · JACKSON LABORATORY · PI DAI, CHENGKAI · 2010 to 2010
$2.7M
(PQA1) Molecular Mechanism of Metformin in CancerR21CA184704 · NCI · JACKSON LABORATORY · PI DAI, CHENGKAI · 2014 to 2015
$419k
NCI NIH HHS P30 CA034196NCI NIH HHS R21 CA184704NIH HHS 1DP2OD007070NIH HHS DP2 OD007070
6 · The paper itself

Abstract

Numerous extrinsic and intrinsic insults trigger the HSF1-mediated proteotoxic stress response (PSR), an ancient transcriptional program that is essential to proteostasis and survival under such conditions. In contrast to its well-recognized mobilization by proteotoxic stress, little is known about how this powerful adaptive mechanism reacts to other stresses. Surprisingly, we discovered that metabolic stress suppresses the PSR. This suppression is largely mediated through the central metabolic sensor AMPK, which physically interacts with and phosphorylates HSF1 at Ser121. Through AMPK activation, metabolic stress represses HSF1, rendering cells vulnerable to proteotoxic stress. Conversely, proteotoxic stress inactivates AMPK and thereby interferes with the metabolic stress response. Importantly, metformin, a metabolic stressor and popular anti-diabetic drug, inactivates HSF1 and provokes proteotoxic stress within tumor cells, thereby impeding tumor growth. Thus, these findings uncover a novel interplay between the metabolic stress sensor AMPK and the proteotoxic stress sensor HSF1 that profoundly impacts stress resistance, proteostasis, and malignant growth.

Indexed as

Stress, PhysiologicalAMP-Activated Protein KinasesAnimalsCell Line, TumorDNA-Binding ProteinsEnzyme ActivationHeat Shock Transcription FactorsHypoglycemic AgentsMetforminMiceMice, Inbred NODMice, SCIDMice, TransgenicNeoplasm ProteinsNeoplasms, ExperimentalPhosphorylationAMP-Activated Protein KinasesDNA-Binding ProteinsHeat Shock Transcription FactorsHsf1 protein, mouseHypoglycemic AgentsMetforminNeoplasm ProteinsTranscription FactorsAMPKHSF1metforminproteostasistumorigenesis

Identifiers

PMID25425574
PMCPMC4339117
OpenAlexW1981975569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.